#type-2-diabetes

#type-2-diabetes

There is, however, no pharmacological treatment currently approved to treat hydrocephalus. Additionally, nearly 20 percent of patients with normal pressure hydrocephalus also have type 2 diabetes and take sodium/glucose cotransporter 2 (SGLT2) inhibitors to manage their blood sugar.

"These cases don't appear to be related to fat, so we want to try and understand what's going on. Is it genetics? Or due to how the pancreas has developed?"

"The drug also lowered patients' blood sugar levels by 1.3% on average, while the overall efficacy of orforglipron in promoting weight loss and controlling diabetes has been met with enthusiasm."

"Women recently diagnosed with type 2 diabetes showed nearly double the risk of pancreatic cancer and almost five times the risk of liver cancer, underscoring crucial health implications."

Mounjaro, a medicine used with diet and exercise, helps adults with type 2 diabetes not adequately controlled and can assist in weight loss.

The compounding industry is stepping up to fill a gap in the market left by brand-name manufacturers like Novo Nordisk and Eli Lilly, who are facing shortages.